Upstream Bio (UPB) Total Current Liabilities: 2023-2025
Historic Total Current Liabilities for Upstream Bio (UPB) over the last 1 years, with Sep 2025 value amounting to $11.9 million.
- Upstream Bio's Total Current Liabilities rose 9.51% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year increase of 9.51%. This contributed to the annual value of $10.7 million for FY2024, which is 64.80% up from last year.
- Per Upstream Bio's latest filing, its Total Current Liabilities stood at $11.9 million for Q3 2025, which was up 8.96% from $10.9 million recorded in Q2 2025.
- Upstream Bio's Total Current Liabilities' 5-year high stood at $11.9 million during Q3 2025, with a 5-year trough of $6.5 million in Q4 2023.
- In the last 3 years, Upstream Bio's Total Current Liabilities had a median value of $10.8 million in 2024 and averaged $10.1 million.
- Data for Upstream Bio's Total Current Liabilities shows a peak YoY soared of 64.80% (in 2024) over the last 5 years.
- Upstream Bio's Total Current Liabilities (Quarterly) stood at $6.5 million in 2023, then skyrocketed by 64.80% to $10.7 million in 2024, then rose by 9.51% to $11.9 million in 2025.
- Its Total Current Liabilities stands at $11.9 million for Q3 2025, versus $10.9 million for Q2 2025 and $9.6 million for Q1 2025.